Adele Gulfo
Director/Board Member at ENPRO INC.
Net worth: 715 444 $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Myrtle Potter | F | 65 |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 6 years |
Saburo Hamanaka | M | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 14 years |
Hiroshi Nomura | M | 66 |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 4 years |
Eric Vaillancourt | M | 60 | 3 years | |
Richard Labelle | M | - | 10 years | |
Robert McLean | M | 59 | 14 years | |
David Hauser | M | 72 | 17 years | |
Michael Mueller | M | 64 | 10 years | |
Shigeyuki Nishinaka | M | 59 |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 2 years |
Masayo Tada | M | 79 |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 4 years |
Larisa R. Joiner | F | - | 11 years | |
Felix Brueck | M | 68 | 10 years | |
Toru Kimura | M | 63 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 3 years |
Benoit Gravel | M | - | 7 years | |
Judith Reinsdorf | F | 60 | 3 years | |
Louis Frederick Stephan | M | - | 7 years | |
Armin Szegedi | M | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | - |
Kenneth d’Entremont | M | - | 6 years | |
Gwen Weiss | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | 6 years |
Menassie Taddese | M | - | 1 years | |
Ian Wildgoose Brown | M | - | 3 years | |
Susan Kalk | F | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | - |
William Abbey | M | 54 | 2 years | |
Tsutomu Nakagawa | M | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 1 years |
Stephen Nelson | M | - | 6 years | |
Hiroyuki Baba | M | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 2 years |
David C. Marek | M | 59 | 3 years | |
Ronald Keating | M | 55 | 1 years | |
Thomas Botts | M | 69 | 12 years | |
Shantanu Narayen | M | 60 | 11 years | |
John Humphrey | M | 58 | 9 years | |
Joseph Bruderek | M | 45 | - | |
Helen Hobbs | M | 71 | 13 years | |
Alison Malloy | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Cristina Dolan | F | 63 |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | 7 years |
Monika Mantilla | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Lisa Church | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Rahilla Zafar | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Steve Danehy | M | - | 12 years | |
Koji Ishida | M | 76 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | - |
Georgia Mitsi | F | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | - |
R. Borcherding | M | 57 |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | 8 years |
Yuichiro Haruyama | M | - |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | - |
Joseph Payne | M | 58 |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Cathy Black | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Laurie Cantileno | M | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Ana Echemendia | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | 5 years |
Nirmal Patel | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Brian Geyser | M | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Yoshiharu Ikeda | M | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | 4 years |
Bronston-Culp Deborah | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | 7 years |
Sharon Rodriguez | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | 2 years |
Marianne Romeo | F | 56 | - | |
Thomas Powell | M | - | 16 years | |
Nisha Kumar | F | 54 |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Jack Britts | M | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | - |
Rakhi Kumar | F | 44 | 6 years | |
Lawrence Flanagan | M | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Mary E. Stutts | F | 68 |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | - |
Steven Bower | M | 65 | 10 years | |
Christina Russ | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | 7 years |
James Michael Gentile | M | - | - | |
Michael Beckley | M | 49 |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Glyn Aeppel | F | 65 |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Tracy Chadwell | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | 8 years |
Julie Gionfriddo | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Denis Patrick | M | - | 14 years | |
Roger Xie | M | 54 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | - |
Andrew Cowper | M | - | 5 years | |
Lisa Frelinghuysen | F | - |
1843 Capital LLC
1843 Capital LLC Investment ManagersFinance 1843 Capital LLC (1843 Capital) is a venture capital firm founded in 2016 by Tracy Killoren Chadwell. The firm is headquartered in Greenwich, Connecticut. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeffrey Kindler | M | 68 | 8 years | |
William Austen | M | 65 | 15 years | |
Sylvain Chrétien | M | 59 | 11 years | |
Marvin Riley | M | 50 | 14 years | |
William Steere | M | 87 | 28 years | |
Frank Karbe | M | 55 | 5 years | |
Stephen Macadam | M | 63 | 12 years | |
Lynn Seely | M | 65 | 5 years | |
Timothy M. Manganello | M | 74 | 15 years | |
Peter van der Velden | M | 62 | 5 years | |
Diane Creel | F | 75 | 14 years | |
JoEllen Dillon | F | 60 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 6 years |
Marc Tessier-Lavigne | M | 64 | 4 years | |
Everett Cunningham | M | 57 | 9 years | |
Marran Ogilvie | F | 55 | 1 years | |
Terrie Curran | F | 55 | 7 years | |
Kathleen Sebelius | F | 75 | 5 years | |
Robert Landry | M | 60 | 4 years | |
Dana George Mead | M | 88 | 12 years | |
Kees van der Graaf | M | 73 | 12 years | |
Sjoerd Steven Vollebregt | M | 69 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | - |
John Sheehan | M | 64 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 6 years |
Michael Brown | M | 82 | 16 years | |
William Herbert Gray | M | 82 | 13 years | |
Robert N. Burt | M | 86 | 11 years | |
Susan E. Sweeney | M | 60 | 12 years | |
B. Bernard Burns | M | 75 | 11 years | |
John Childress | M | 66 | 19 years | |
John Mascotte | M | 84 | 4 years | |
Yi Ning Zhao | M | 53 | 8 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 81 | 81.00% |
United Kingdom | 14 | 14.00% |
Canada | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Adele Gulfo
- Personal Network